IFG Advisory LLC Purchases 257 Shares of The Clorox Company (NYSE:CLX)

IFG Advisory LLC increased its position in The Clorox Company (NYSE:CLX) by 5.7% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 4,733 shares of the company’s stock after buying an additional 257 shares during the period. IFG Advisory LLC’s holdings in Clorox were worth $675,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Schroder Investment Management Group raised its holdings in shares of Clorox by 384.0% during the 2nd quarter. Schroder Investment Management Group now owns 64,175 shares of the company’s stock valued at $10,206,000 after purchasing an additional 50,917 shares in the last quarter. Adage Capital Partners GP L.L.C. acquired a new position in Clorox in the 3rd quarter valued at $6,605,000. Eagle Rock Investment Company LLC bought a new position in Clorox in the 4th quarter worth $2,940,000. Teacher Retirement System of Texas lifted its position in Clorox by 742.8% during the 3rd quarter. Teacher Retirement System of Texas now owns 78,713 shares of the company’s stock worth $10,316,000 after acquiring an additional 69,373 shares during the last quarter. Finally, Korea Investment CORP boosted its holdings in Clorox by 279.4% during the third quarter. Korea Investment CORP now owns 164,209 shares of the company’s stock valued at $21,521,000 after acquiring an additional 120,926 shares during the period. Institutional investors own 78.53% of the company’s stock.

Clorox Stock Up 0.3 %

NYSE CLX opened at $153.14 on Friday. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 11.37. The company has a market cap of $19.01 billion, a price-to-earnings ratio of 243.08, a PEG ratio of 2.34 and a beta of 0.43. The company has a 50 day moving average of $150.70 and a 200-day moving average of $140.93. The Clorox Company has a 1-year low of $114.68 and a 1-year high of $178.21.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Thursday, February 1st. The company reported $2.16 earnings per share for the quarter, beating the consensus estimate of $1.08 by $1.08. The firm had revenue of $1.99 billion during the quarter, compared to analysts’ expectations of $1.80 billion. Clorox had a return on equity of 319.41% and a net margin of 1.09%. The company’s quarterly revenue was up 16.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.98 EPS. On average, equities research analysts expect that The Clorox Company will post 5.52 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 10th. Shareholders of record on Wednesday, April 24th will be issued a $1.20 dividend. This represents a $4.80 dividend on an annualized basis and a dividend yield of 3.13%. The ex-dividend date of this dividend is Tuesday, April 23rd. Clorox’s dividend payout ratio is presently 761.92%.

Analysts Set New Price Targets

A number of equities analysts have recently commented on CLX shares. Bank of America upgraded Clorox from an “underperform” rating to a “neutral” rating and lifted their price objective for the stock from $120.00 to $150.00 in a research note on Friday, December 15th. The Goldman Sachs Group assumed coverage on Clorox in a research report on Friday, March 1st. They issued a “sell” rating and a $140.00 price objective for the company. StockNews.com raised shares of Clorox from a “sell” rating to a “hold” rating in a research report on Thursday, December 7th. Barclays increased their price target on shares of Clorox from $115.00 to $118.00 and gave the company an “underweight” rating in a report on Tuesday, January 16th. Finally, DA Davidson reaffirmed a “neutral” rating and issued a $162.00 price target on shares of Clorox in a report on Monday, February 5th. Four analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has issued a buy rating to the company. According to data from MarketBeat.com, Clorox currently has a consensus rating of “Hold” and a consensus price target of $147.06.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.